Results inconsistent for association with bile acid sequestrant use depending on diabetes and liver disease status. HealthDay News — The use of cholesterol absorption inhibitors is associated with a ...
With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.
New late-breaking clinical trial data presented at ACC and published simultaneously in JACC show benefit of investigational medicine AZD0780 on top of standard of care WILMINGTON, Del.--(BUSINESS WIRE ...
Scientists think those cholesterol-lowering statins might be doing something else we didn't know about: protecting our brains ...
Statins are considered safe and effective, but they may not be right for everyone to lower cholesterol.
Analysis could lead to future therapies to prevent deadly cardiac events. The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Millions of people take statins like Simvastatin (above) to lower their cholesterol levels. Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart ...
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant and clinically meaningful cuts in low ...
A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback